Compare GH & FNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GH | FNB |
|---|---|---|
| Founded | 2011 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 6.0B |
| IPO Year | 2018 | N/A |
| Metric | GH | FNB |
|---|---|---|
| Price | $101.92 | $17.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 21 | 8 |
| Target Price | ★ $82.76 | $18.31 |
| AVG Volume (30 Days) | 2.2M | ★ 4.7M |
| Earning Date | 10-29-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.74% |
| EPS Growth | N/A | ★ 28.48 |
| EPS | N/A | ★ 1.40 |
| Revenue | $902,569,000.00 | ★ $1,587,400,000.00 |
| Revenue This Year | $34.72 | $17.82 |
| Revenue Next Year | $26.46 | $8.12 |
| P/E Ratio | ★ N/A | $12.51 |
| Revenue Growth | ★ 30.38 | 6.34 |
| 52 Week Low | $29.91 | $10.88 |
| 52 Week High | $112.43 | $17.75 |
| Indicator | GH | FNB |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 70.05 |
| Support Level | $100.21 | $16.34 |
| Resistance Level | $109.59 | $17.75 |
| Average True Range (ATR) | 4.22 | 0.33 |
| MACD | -1.65 | 0.10 |
| Stochastic Oscillator | 13.51 | 86.81 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.